Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChanBan: Combination Bupropion and Varenicline for Smoking Cessation
NCT00587769Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline, bupropion in Tobacco Use Disorder (TUD), sponsored by Mayo Clinic. Started Jul 2007; status: completed.
02
Drugs
vareniclinebupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00587769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00587769.